Shima Hadidchi, MD , can help you assess whether the oral form of semaglutide or another weight loss medication might be appropriate for your needs, based on your medical history and weight loss goals
Novo Nordisks announcement explicitly positions the offer as a safety effort encouraging patients to choose real, FDA-approved semaglutide medicines and avoid risky, potentially unsafe knockoffs. With reports of contamination, incorrect dosing, and counterfeit distribution on the rise, the company is attempting to reclaim a patient population at risk of drifting outside regulated channels
Kickstart your journey by scheduling a personalized consultation with our skilled professionals
Novo Nordisk has officially submitted a higher 7.2 mg dose of once-weekly semaglutide (Wegovy) to the European Medicines Agency (EMA)
The dose is relatively modest at 1 billion CFU per capsule, but B